‘How can the UK better capitalize on its life sciences prowess?’ was the first panel at Optimum’s 15th Annual Healthcare Conference. Led by Chair Dan Mahony, UK Government Life Sciences Investment Envoy & Chair of BIA, the panel participants brought with them a wealth of experience: Annalisa Jenkins, Non-Executive Director, Genomics England; Allan Marchington, Managing […]
Optimum Strategic Communications celebrated its 15th Annual Healthcare Investor Conference – marking its crystal anniversary – and what a sparkler it was! Optimism, preparation, and resilience, these were the key takeaways from our wonderful speakers on Wednesday 11 October at the Wellcome Trust. Check out our panel summaries below to learn more or to rediscover […]
Thanks in part to the massive success of Novo Nordisk’s obesity drug Wegovy and its counterpart for diabetes, Ozempic, Novo Holdings’ coffers have been swelling. It now manages a huge $30bn investment fund. In a fascinating fireside chat at this year’s Optimum conference, Novo Holdings’ CEO Kasim Kutay provided a unique insight into this growing […]
The UK is in a pretty strong position when it comes to growing its life science sector – but there is undoubtedly room for improvement. That was the verdict of Professor Sir Chris Whitty, Chief Medical Officer for England, and the keynote speaker at this year’s Optimum Strategic Communications Conference, which was held on Wednesday […]
Last week, Optimum held its 15th Annual Healthcare Investor Conference – marking its crystal anniversary – and what a sparkler it was! As soon as the clock struck 12, attendees started pouring into the Wellcome Collection venue. Had they heard champagne was to be served, and didn’t want to miss out? Maybe. Did they want […]
